Natural Product: NPC538289

Natural Product IDNPC538289
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2~{R})-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methyl-butyl)chroman-4-one
IUPAC Name (2~{R})-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methyl-butyl)chroman-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey AUWAYTAMBAVTLA-MRXNPFEDSA-N
Standard InCHI InChI=1S/C20H22O7/c1-20(2,26)6-5-11-13(22)8-17-18(19(11)25)15(24)9-16(27-17)10-3-4-12(21)14(23)7-10/h3-4,7-8,16,21-23,25-26H,5-6,9H2,1-2H3/t16-/m1/s1
SMILES CC(C)(O)CCC1=C(O)C=C2O[C@@H](C3=CC=C(O)C(O)=C3)CC(=O)C2=C1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   374.14 Volume:   371.883
?
Van der Waals volume.
Dense:   1.006 LogP:   1.891
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.245
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.393
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   18.0
TPSA:   127.45
?
Topological Polar Surface Area.
H-Bond Acceptor:   7.0
H-Bond Donor:   5.0 Rings:   3.0
Heavy Atoms:   7.0

MedChem Properties

QED Drug-Likeness Score:   0.521 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.363 Fsp3:   0.35
MCE-18:   69.259
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.583 Fluc inhibitor:   0.6
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.662
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.255
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.142 Promiscuous compounds:   0.111

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.206 MDCK Permeability:   -4.83
Pgp-inhibitor:   0.044 Pgp-substrate:   0.003
PAMPA:   0.305
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.029
20% Bioavailability (F20%):   0.71 30% Bioavailability (F30%):   0.986
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.821
Plasma Protein Binding (PPB):   96.268% Volume Distribution (VD):   -0.19
Fu: 3.699%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.993
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.689
BSEP inhibitor:   0.605

ADMET: Metabolism

CYP1A2-inhibitor:   0.876 CYP1A2-substrate:   0.86
CYP2C19-inhibitor:   0.008 CYP2C19-substrate:   0.078
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.004 CYP2D6-substrate:   0.979
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.909
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.998
HLM stability:   0.98
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  12.204 Half-life (T1/2):  1.478

ADMET: Toxicity

hERG Blockers:  0.047 hERG Blockers (10um):  0.504
Human Hepatotoxicity (H-HT):  0.807 Drug-induced Liver Injury (DILI):  0.248
AMES Toxicity:  0.754 Rat Oral Acute Toxicity:  0.468
Maximum Recommended Daily Dose:  0.76 Skin Sensitization:  0.99
Carcinogencity:  0.377 Eye Corrosion:  0.006
Eye Irritation:  0.972 Respiratory Toxicity:  0.882
Drug-induced Neurotoxicity:  0.038 Ototoxicity:  0.798
Hematotoxicity:  0.103 Drug-induced Nephrotoxicity:  0.546
Genotoxicity:  0.97 RPMI-8226 Immunitoxicity:  0.091
A549 Cytotoxicity:  0.782 Hek293 Cytotoxicity:  0.326
BCF:   0.784
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.361
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.898
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.148
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19912 Vellozia nanuzae Species Velloziaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO19912 Vellozia nanuzae Species Velloziaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC538289 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7273 Intermediate Similarity NPC261063
0.6716 Remote Similarity NPC213896
0.6667 Remote Similarity NPC321779
0.6271 Remote Similarity NPC321011
0.6271 Remote Similarity NPC294852
0.6271 Remote Similarity NPC188679
0.6232 Remote Similarity NPC472629
0.6154 Remote Similarity NPC125855
0.6143 Remote Similarity NPC488556
0.5938 Remote Similarity NPC1089
0.5833 Remote Similarity NPC471209
0.5833 Remote Similarity NPC472627
0.5811 Remote Similarity NPC488557
0.5797 Remote Similarity NPC35038
0.5733 Remote Similarity NPC27337
0.5733 Remote Similarity NPC472598
0.5658 Remote Similarity NPC488555
0.5658 Remote Similarity NPC484418
0.5634 Remote Similarity NPC228504
0.5574 Remote Similarity NPC324386
0.5522 Remote Similarity NPC610133
0.5467 Remote Similarity NPC472628
0.5441 Remote Similarity NPC223500
0.5441 Remote Similarity NPC480158
0.541 Remote Similarity NPC1612
0.541 Remote Similarity NPC183959
0.5405 Remote Similarity NPC185276
0.5333 Remote Similarity NPC278778
0.5333 Remote Similarity NPC488558
0.5333 Remote Similarity NPC298692
0.5323 Remote Similarity NPC482119
0.5323 Remote Similarity NPC482120
0.5303 Remote Similarity NPC480991
0.5238 Remote Similarity NPC192083
0.5217 Remote Similarity NPC166689
0.5205 Remote Similarity NPC290133
0.5195 Remote Similarity NPC45849
0.5195 Remote Similarity NPC195796
0.519 Remote Similarity NPC474055
0.5161 Remote Similarity NPC312391
0.5147 Remote Similarity NPC21350
0.5135 Remote Similarity NPC64915
0.5125 Remote Similarity NPC472634
0.5067 Remote Similarity NPC224851
0.5067 Remote Similarity NPC164272
0.5067 Remote Similarity NPC470327
0.5065 Remote Similarity NPC488554
0.5065 Remote Similarity NPC472630
0.5062 Remote Similarity NPC321399

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC538289 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5238 Remote Similarity NPD2393 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data